07.01.2013 Views

[Abstract Title]. - Society for Neuroscience

[Abstract Title]. - Society for Neuroscience

[Abstract Title]. - Society for Neuroscience

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

1 Mol. Biomedicine, CINVESTAV-IPN, Distrito Federal, Mexico; 2 Kline Inst., New York, NY;<br />

3 Insituto Nacional de Neurología y Neurocirugía Manuel Velazco Suárez, Distrito Federal,<br />

Mexico<br />

<strong>Abstract</strong>: Alzheimer Disease (AD) is characterized by hallmarks lesions: neuritic plaques and<br />

neurofibrillary tangles (NFT). Progressive dementia is correlated with the appearance of NFT in<br />

different regions of hippocampus and enthorinal cortex. These NFT are mainly composed by<br />

filamentous aggregates of Tau protein as paired helical filaments (PHF). Previous studies<br />

showed a proteolytic resistant fragment named as PHF core, containing a main portion of the Tau<br />

microtubule binding domain, suggesting that this fragment is important <strong>for</strong> Tau abnormal<br />

polymerization in AD. In the present study, we modified neural precursor cells primary cultures<br />

(NPCs) by a retroviral system, in order to of evaluated the factor involve in the aggregates<br />

generation of Tau. PHF core was used in two ways: 1) as a soluble fraction and 2) with a<br />

membrane localization (IFNγR1-NMF), to elucidate the possible role of the membrane substrate<br />

as a nucleation center <strong>for</strong> Tau polymerization. We observed that soluble PHF-core was able to<br />

<strong>for</strong>m a moderate quantity of β-sheet structures, but interestingly the presence of these structures<br />

was higher in cells with IFNγR1-NMF expression. These data suggest that the interaction<br />

between PHF core and plasma membrane could regulate the <strong>for</strong>mation of abnormal fibrillary<br />

deposits.<br />

Disclosures: K. Lira-De Leon , None; M.A. De Anda-Hernandez, None; P. Figueroa-<br />

Corona, None; M. Cardenas-Aguayo, None; V. Campos-Peña, None; M.A. Meraz-Rios,<br />

None.<br />

Poster<br />

245. Tau and Alzheimer's disease<br />

Time: Sunday, November 16, 2008, 1:00 pm - 5:00 pm<br />

Program#/Poster#: 245.20/P2<br />

Topic: C.01.h. Tau<br />

<strong>Title</strong>: Expression of soluble and chimerical truncated tau (151-391) in neuronal cultures<br />

Authors: *M. A. DE ANDA-HERNANDEZ 1 , K. I. LIRA-DE LEON 1 , P. FIGUEROA-<br />

CORONA 1 , V. CAMPOS-PEÑA 2 , M. A. MERAZ-RIOS 1 ;<br />

1 Mol. Biomedicine, CINVESTAV-IPN, Mexico, Mexico; 2 Inst. Nacional de Neurologia y<br />

neurocirugia manuel velazco suarez, mexico, Mexico<br />

<strong>Abstract</strong>: Alzheimer disease (AD) is a neurodegenerative progressive encephalic disorder,<br />

characterized by behavioral changes associated to memory lost and disorientation. Is the most

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!